跳至主要内容
临床试验/CTRI/2017/04/008443
CTRI/2017/04/008443尚未招募1 期

CLINICAL STUDY ON SAUVARCHALADI CHOORNA AND PADMAKADI HERBAL NEBULIZATION IN THE MANAGEMENT OF TAMAKA SHWASA W.S.R TO CHILDHOOD BRONCHIAL ASTHMA

parul institute of ayurveda1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2017年1月5日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
REDUCES THE EPISODES OF ASTHMA ATTACK

研究概览

简要总结

Bronchial asthma is a disease characterized byan increased responsiveness of the airways to various stimuli. It manifests bywidespread narrowing of the airways causing paroxysmal dyspnea, wheezing orcough. The approximated estimation suggests the prevalenceof 334 million cases globally. This alarmingly high prevalence is found especiallyamong children, because of changes in life style, rapid industrialization andincrease in air pollution etc. In Ayurveda proper nebulization therapy has been not explained but the processof dhumpana & dhoopana nasya may be analogous in some extent. Thus, thiswork gives the glimpse of concept of inhalation therapy described in Ayurvedicclassics & establishment of newer concept of drug administration route i.e;through nebulization along with Sauvarchaladi choorna will be assessed inpatients of Tamaka Shwasa.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
2.00 Year(s) 至 12.00 Year(s)(—)
性别
All

入选标准

  • classical symptoms of childhood Asthma like wheezing, shotness of breath etc will be included.
  • patients who are known case of Bronchial Asthma.

排除标准

  • severe asthma cases with complications like suspected infections, heart diseases, pneumonia, airway lesions etc.
  • chronic debilating diseases like TB, AIDS, endocrine complaints etc.

结局指标

主要结局

REDUCES THE EPISODES OF ASTHMA ATTACK

时间窗: 12 weeks | follow up monthly once

次要结局

  • REDUCES COMMON CHIEF COMPLAINTS OF ASTHMA(12 WEEKS)

研究者

发起方
parul institute of ayurveda
申办方类型
Private medical college

研究点 (1)

Loading locations...

相似试验